Teleflex Incorporated (TFX)
Company Description
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide.
It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.
The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices.
It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments.
The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings.
It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services.
The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets.
The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.
| Country | United States |
| Founded | 1943 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 15,500 |
| CEO | Liam J. Kelly |
Contact Details
Address:
550 E Swedesford Rd, Suite 400 Wayne, Pennsylvania 19087 United States | |
| Phone | 610-225-6800 |
| Website | teleflex.com |
Stock Details
| Ticker Symbol | TFX |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000096943 |
| CUSIP Number | 879369106 |
| ISIN Number | US8793691069 |
| Employer ID | 23-1147939 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Liam J. Kelly | Chairman, President and Chief Executive Officer |
| Thomas E. Powell | Executive Vice President and Chief Financial Officer |
| Cameron P. Hicks | Corporate Vice President and Chief Human Resources Officer |
| Jay White | Corporate Vice President and President of Global Commercial |
| James P. Winters | Corporate Vice President, Manufacturing and Supply Chain |
| John R. Deren | Corporate Vice President and Chief Accounting Officer |
| John Hsu C.F.A. | Vice President of Investor Relations |
| Daniel V. Logue | Corporate Vice President, General Counsel and Secretary |
| Howard Cyr | Corporate Vice President and Chief Compliance Officer |
| Matt Tomkin | Vice President of Corporate Development |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 26, 2023 | SD | Form - SD |
| May 11, 2023 | 8-K | Current Report |
| May 10, 2023 | 144 | Filing |
| May 4, 2023 | 10-Q | Quarterly Report |
| May 4, 2023 | 8-K | Current Report |
| Apr 14, 2023 | ARS | Filing |
| Mar 31, 2023 | DEF 14A | Other definitive proxy statements |
| Mar 24, 2023 | 8-K | Current Report |
| Mar 10, 2023 | PRE 14A | Other preliminary proxy statements |
| Feb 23, 2023 | 10-K | Annual Report |